American Heart Journal
Volume 146, Issue 5 , Pages 764-774 , November 2003

Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST–segment elevation acute coronary syndromes: risk stratification and therapeutic intervention

  • James L Januzzi, MD

      Affiliations

    • Cardiology Divisions, Massachusetts General Hospital, Boston, Mass, USA
    • Corresponding Author InformationReprint requests: William E. Boden, MD, Director, Cardiology Division, Hartford Hospital, 80 Seymour Street, Box 5037, Hartford, CT, 06102-5037, USA.
    • ,
  • Christopher P Cannon, MD

      Affiliations

    • Brigham and Women's Hospital, Boston, Mass, USA
    • ,
  • Pierre Theroux, MD

      Affiliations

    • Montreal Heart Institute, Montreal, Quebec, Canada
    • ,
  • William E Boden, MD

      Affiliations

    • Hartford Hospital, Hartford, Conn, USA

Received 30 September 2002 ,Accepted 13 May 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-8703(03)00437-X

doi: 10.1016/S0002-8703(03)00437-X

American Heart Journal
Volume 146, Issue 5 , Pages 764-774 , November 2003

Article Tools

* Image Usage & Resolution